Cargando…
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)
Autores principales: | Scaroni, Carla, Mondin, Alessandro, Ceccato, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587923/ https://www.ncbi.nlm.nih.gov/pubmed/35616760 http://dx.doi.org/10.1007/s11102-022-01222-2 |
Ejemplares similares
-
Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy
por: Barbot, Mattia, et al.
Publicado: (2022) -
Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018) -
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre
por: Mondin, Alessandro, et al.
Publicado: (2023) -
Clinical use of pasireotide for Cushing’s disease in adults
por: Ceccato, Filippo, et al.
Publicado: (2015) -
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)